MRI and Fine Needle Aspiration in the Diagnosis of Parotid Tumors

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Completed
CT.gov ID
NCT05152056
Collaborator
(none)
133
1
24
168.7

Study Details

Study Description

Brief Summary

What value is given to MRI diffusion and perfusion sequences in the diagnosis of parotid tumors? Is a fine needle aspiration associated with MRI systematically necessary? The aim of the research is to study the performance of diffusion and perfusion MRI sequences in the diagnosis of parotid tumors on a large series of cases.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    133 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Role of MRI and Fine Needle Aspiration in the Diagnosis of Parotid Tumors
    Actual Study Start Date :
    Nov 15, 2021
    Actual Primary Completion Date :
    Dec 9, 2021
    Actual Study Completion Date :
    Dec 9, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Study the performance of diffusion and perfusion MRI sequences in the diagnosis of parotid tumors on a large series of cases [Files analysed retrospectively from January 1, 2009 to June 30, 2020 will be examined]]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion criteria:
    • Major subject (≥18 years old)

    • Minor subject (<18 years old)

    • Operated for a parotid tumor at Strasbourg University Hospital between January 2009 and June 2020

    • Having had in the preoperative assessment an MRI of the parotid, also carried out at the Strasbourg University Hospital.

    • Subject (and / or his parental authority) not having expressed, after being informed, his opposition to the reuse of his data for the purposes of this research.

    Exclusion criteria:
    • Subject (or his parents) who expressed his (their) opposition to participating in the study

    • Lack of pathological or MRi results

    • Subject under guardianship, curatorship or safeguard of justice

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service d'ORL et de Chirurgie Cervico-Faciale - Hôpitaux Universitaires de Strasbourg Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT05152056
    Other Study ID Numbers:
    • 8454
    First Posted:
    Dec 9, 2021
    Last Update Posted:
    Dec 10, 2021
    Last Verified:
    Nov 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 10, 2021